Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001-2007

Pediatric Pulmonology

Volumn 46, Issue 8, 2011, Pages 770-776

  Briesacher, Becky A ^a   Quittner, Alexandra L ^b   Fouayzi, Hassan ^a   Zhang, Jie ^c   Swensen, Andrine ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Department of Biology   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

cystic fibrosis; healthcare utilization

Indexed keywords

ANTIBIOTIC AGENT; DORNASE ALFA; VITAMIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; CHILD; COMORBIDITY; CYSTIC FIBROSIS; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITALIZED CHILD; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; OUTPATIENT CARE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PSEUDOMONAS AERUGINOSA; REVIEW; SCHOOL CHILD; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DATABASES, FACTUAL; DEOXYRIBONUCLEASE I; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INSURANCE; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 79960383427     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21441     Document Type: Review

References (17)

1. Cystic Fibrosis Foundation Patient Registry, 2007. Annual data report. Bethesda, MD: Cystic Fibrosis Foundation; 2008.
2. Accurso FJ,. Pulmonary and critical care updates: update in cystic fibrosis 2007. Am J Respir Crit Care Med 2008; 177: 1058-1061.
3. Johnson C, Butler SM, Konstan MW, Morgan W, Wohl ME,. Factors influencing outcomes in cystic fibrosis: a center-based analysis. Chest 2003; 123: 20-27. (Pubitemid 36126709)
4. Sawicki GS, Sellers DE, Robinson WM,. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros 2009; 8: 91-96.
5. Weiner JR, Toy EL, Sacco P, Duh MS,. Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature. Expert Opin Pharmacother 2008; 9: 751-766. (Pubitemid 351566192)
6. US Congress Office of Technology Assessment. Cystic fibrosis and DNA tests: implications of carrier screening. Washington, DC; 1992.
7. Lieu TA, Ray GT, Farmer G, Shay GF,. The cost of medical care for patients with cystic fibrosis in a health maintenance organization. Pediatrics 1999; 103: e72.
8. Ouyang L, Grosse SD, Amendah DD, Schechter MS,. Healthcare expenditures for privately insured people with cystic fibrosis. Pediatr Pulmonol 2009; 44: 989-996.
9. Adamson D, Chang S, Hansen L,. Health research data for the real world: the MarketScan databases, in White Paper. Ann Arbor, MI: Thomson Medstat; 2005.
10. Thomson Medstat. MarketScan databases userguide and database dictionary. Ann Arbor, MI: Thomson Medstat; 2006.
11. Rector TS, Wickstrom SL, Shah M, Thomas Greeenlee N, Rheault P, Rogowski J, Freedman V, Adams J, Escarce JJ,. Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions. Health Serv Res 2004; 39: 1839-1857. (Pubitemid 39601255)
12. Modi AC, Lim CS, Yu N, Geller D, Wagner MH, Quittner AL,. A multi-method assessment of treatment adherence for children with cystic fibrosis. J Cyst Fibros 2006; 5: 177-185. (Pubitemid 44063951)
13. Quittner AL, Barker DH, Marciel KK, Grimley ME,. Cystic fibrosis: a model for drug discovery and patient care. Handbook of Pediatric Psychology. (in press).
14. US Department of Labor and Bureau of Labor Statistics. Consumer Price Indexes. Volume 2007; 2006. p. Available from:.
15. Ash A, Ellis RP, Pope G, Ayanian J, Bates D, Burstin H, Iezzoni L, McKay E, Yu W,. Using diagnoses to describe populations and predict costs. Health Care Financ Rev 2000; 21: 7-28.
16. Petersen LA, Pietz K, Woodard LD, Byrne M,. Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes. Med Care 2005; 43: 61-67. (Pubitemid 40137615)
17. Redelmeier DA, Tan SH, Booth GL,. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998; 338: 1516-1520. (Pubitemid 28226280)